&nbsp;

H-FIT_PCC_4160_CCAM_Postcard_FRCA_PRINT

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Postcard_FRCA_V05

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Poster_FRCA_PRINT

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Poster_FRCA_V04

Dec 1969

Regimen

MTRX(HD)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

, Collapse Show fewer tags

Intent: Curative

Drugs Used:

methotrexate,

leucovorin

... Show more tags

Quick Link(s):

Regimen Monograph

Guidelines and Advice

Minimal Residual Disease Testing in Acute Leukemia

Status: Current
ID: MOTAC-6
Version: 2

Sep 2020

Document

MucinousOvarianCancerTreatmentPathwayMap_2020-01.pdf

Mar 2020

Document

hpb-locations-26-10-20.xml

Oct 2020

Document

hpb-26-10-20.html

Oct 2020

Regimen

MPC+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Funding:

ODB - General Benefit

procarbazine

, Collapse Show fewer tags

Drugs Used:

riTUXimab (Unfunded),

Quick Link(s):

Regimen Monograph

Regimen

MFOLFOX6+TRAS

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer